Velocity is a biomedical research firm that studies drugs, treatments, vaccines and medical devices for a wide array of ...

Detailed price information for Cogent Biosciences Inc (COGT-Q) from The Globe and Mail including charting and trades.

and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly ...

Clinical research company Fortrea Holdings (NASDAQ:FTRE) beat Wall Street’s revenue expectations in Q1 CY2025, but sales fell by 1.6% year on year to $651.3 million. The company’s full-year revenue ...

Detailed price information for Stoke Therapeutics Inc (STOK-Q) from The Globe and Mail including charting and trades.

However, the nuts and bolts of clinical trials are rooted in quite traditional methods and processes. Fortrea aims to modernize the way clinical trials are run with innovation that combines the ...

Clinical trials provide access to novel treatments, comprehensive care, and closer monitoring, improving outcomes for GI cancer patients. Multidisciplinary planning and biomarker testing are crucial ...

Peer Navigation for HIV-Associated Kaposi Sarcoma in Kenya: The Power of the Survivor's Voice Latin America's cultural diversity, political instability, and socioeconomic inequality contribute to ...

Fortrea leads on an average of 40-50 agency meetings globally each year, supporting 10-12 clinical development plans annually. Additionally, we have conducted and are actively managing 225+ Phase II ...

Clinical trials are an essential part of medical breakthroughs that help patients, but getting them off the ground and running them is often fraught with challenges. Specifically, qualification ...

The growth is driven by pharma and biotech companies outsourcing clinical trials to specialized providers. Since late-stage trials are larger and more complex, they are more frequently outsourced ...